Category:
API Equipment
Standard:
N;
China GMP
Form: tablet
Strength: 20mg, 50mg
Indication: Non-small Cell Lung Cancer and Metastatic Colorectal Cancer.
This product belongs to the oral small-molecule kinase inhibitor category, manufactured under strict GMP standards. It typically features a specialized capsule formulation designed for precise dosage delivery and chemical stability during storage.